MCU and fibrolamellar hepatocellular carcinoma: In fibrolamellar carcinoma (FLC), for example, MCU upregulation suppresses branched-chain amino acid degradation and the urea cycle by downregulating the transcription factor KLF15, facilitating anabolic metabolism over catabolism and further promoting tumor growth [47].